BCC

Boise Cascade has delivered a 62.6% total return over the past 5 years, which puts fresh focus on a simple question for anyone looking at the stock today.

Loop Capital’s decision to cut Boise Cascade (BCC) to Hold from Buy, along with a reduced reference price, put fresh attention on how the building products supplier is currently valued by the market.

The women-owned medical aesthetics practice, led by national Galderma trainer Rachel Ryan, FNP-C, joins the top one percent of Galderma accounts in the country and expands its team and treatment menu BOISE, Idaho, Oct.

Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks.

Housing affordability in the Midwest is getting squeezed as prices climb and mortgage rates sit above 7%, and that pressure is reshaping where and how Americans can afford to live.

Boise Cascade (BCC) is back in focus after recent share price moves, with the stock closing at US$76.59. Investors are reassessing the building products supplier as they weigh recent trading performance. Recent moves put that US$76.59 share price into context.

Boise Cascade currently trades at $77.16 per share and has shown little upside over the past six months, posting a middling return of 2.9%. The stock also fell short of the S&P 500’s 21.4% gain during that period.

As the Q2 earnings season comes to a close, it’s time to take stock of this quarter’s best and worst performers in the industrial distributors industry, including Boise Cascade (NYSE:BCC) and its peers.

Here are five key things investors need to know to start the trading day.